{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:12:16Z","timestamp":1774386736423,"version":"3.50.1"},"reference-count":105,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>Primary hyperparathyroidism (PHPT) is the third most common endocrine disease. Kidney is a target of both chronic elevated PTH and calcium in PHPT. The classic PHPT complications of symptomatic kidney stones and nephrocalcinosis have become rare and the PHPT current presentation is asymptomatic with uncertain and long-lasting progression. Nonetheless, the routine use of imaging and of biochemical determinations have revealed the frequent occurrence of asymptomatic kidney stones, hypercalciuria and reduced kidney function in asymptomatic PHPT patients. Though the pathogenesis is far from being elucidated, PHPT is associated with reduced renal function, in terms of estimated glomerular filtration rate, and related increased morbidity and mortality. In the last decade, the effort of the Kidney Disease: Improving Global Outcomes (KDIGO) panel of experts highlighted that even mild reduction of kidney function is associated with increased risk of cardiovascular disease. These considerations provided the basis for the Fourth Workshop recommendations of a more extensive diagnostic workout about kidney features and of wider criteria for parathyroid surgery including asymptomatic kidney disease. Moreover, kidney involvement in PHPT is likely to be affected by variants of genes coding the key molecules regulating the calcium and ions renal handling; these features might have clinical relevance and should be considered both during diagnostic workout and follow-up. Finally, the effects of parathyroid surgery and of medical treatment on kidney involvement of PHPT are reviewed.<\/jats:p>","DOI":"10.1530\/eje-16-0430","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T01:29:28Z","timestamp":1473211768000},"page":"R39-R52","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":53,"title":["MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects"],"prefix":"10.1093","volume":"176","author":[{"given":"C","family":"Verdelli","sequence":"first","affiliation":[{"name":"1Laboratory of Experimental EndocrinologyIRCCS Istituto Ortopedico Galeazzi, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Corbetta","sequence":"additional","affiliation":[{"name":"1Laboratory of Experimental EndocrinologyIRCCS Istituto Ortopedico Galeazzi, Milan, Italy"},{"name":"2Endocrinology ServiceDepartment of Biomedical Sciences for Health, University of Milan, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2016111418002121000_176.1.R39.1","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) . KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International 2013 3 1\u2013150. (doi:10.1038\/kisup.2012.76)","DOI":"10.1038\/kisup.2012.76"},{"key":"2016111418002121000_176.1.R39.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1414"},{"key":"2016111418002121000_176.1.R39.3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03345354","article-title":"Risk factors associated to kidney stones in primary hyperparathyroidism","volume":"28","author":"Corbetta","year":"2005","journal-title":"Journal of Endocrinological Investigation"},{"key":"2016111418002121000_176.1.R39.4","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0032"},{"key":"2016111418002121000_176.1.R39.5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3708"},{"key":"2016111418002121000_176.1.R39.6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","article-title":"Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism","volume":"34","author":"Tuna","year":"2016","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"2016111418002121000_176.1.R39.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-010-0271-8"},{"key":"2016111418002121000_176.1.R39.8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0569"},{"key":"2016111418002121000_176.1.R39.9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40618-015-0261-3","article-title":"Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism","volume":"38","author":"Marcocci","year":"2015","journal-title":"Journal of Endocrinological Investigation"},{"key":"2016111418002121000_176.1.R39.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1413"},{"key":"2016111418002121000_176.1.R39.11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1308\/003588413X13629960048712","article-title":"Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism","volume":"95","author":"Rowlands","year":"2013","journal-title":"Annals of the Royal College of Surgeons of England"},{"key":"2016111418002121000_176.1.R39.12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2014.01.016","article-title":"Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism","volume":"84","author":"Elkoushy","year":"2014","journal-title":"Urology"},{"key":"2016111418002121000_176.1.R39.13","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2014-4548","article-title":"Hypercalciuria may persist after successful parathyroid surgery and it is associated with parathyroid hyperplasia","volume":"100","author":"Palmieri","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.14","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1210\/jc.2013-3903","article-title":"The impact of obesity on the presentation of primary hyperparathyroidism","volume":"99","author":"Tran","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjsurg.2014.09.030","article-title":"Low 24-hour urine calcium levels in patients with sporadic primary hyperparathyroidism: is further evaluation warranted prior to parathyroidectomy?","volume":"210","author":"O\u2019Connell","year":"2015","journal-title":"American Journal of Surgery"},{"key":"2016111418002121000_176.1.R39.16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021597"},{"key":"2016111418002121000_176.1.R39.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1221"},{"key":"2016111418002121000_176.1.R39.18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneph.2016.59","article-title":"Localization and function of the renal calcium-sensing receptor","volume":"12","author":"Riccardi","year":"2016","journal-title":"Nature Review Nephrology"},{"key":"2016111418002121000_176.1.R39.19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0842"},{"key":"2016111418002121000_176.1.R39.20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1772"},{"key":"2016111418002121000_176.1.R39.21","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-009-9211-1"},{"key":"2016111418002121000_176.1.R39.22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0901"},{"key":"2016111418002121000_176.1.R39.23","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12398"},{"key":"2016111418002121000_176.1.R39.24","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/cen.13046","article-title":"The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism","volume":"85","author":"Riss","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"2016111418002121000_176.1.R39.26","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jc.2015-3964","article-title":"Thiazide-associated hypercalcemia: incidence and association with primary hyperparathyroidism over two decades","volume":"101","author":"Griebeler","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.27","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.59.692.350"},{"key":"2016111418002121000_176.1.R39.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1990.tb00166.x"},{"key":"2016111418002121000_176.1.R39.29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cen.12206","article-title":"What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"79","author":"Yu","year":"2013","journal-title":"Clinical Endocrinology"},{"key":"2016111418002121000_176.1.R39.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03958.x"},{"key":"2016111418002121000_176.1.R39.31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS).","volume":"73","author":"Yu","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"2016111418002121000_176.1.R39.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60507-9"},{"key":"2016111418002121000_176.1.R39.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1106636"},{"key":"2016111418002121000_176.1.R39.34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ki.2013.251","article-title":"A crystal-clear mechanism of chronic kidney disease","volume":"84","author":"Kurts","year":"2013","journal-title":"Kidney International"},{"key":"2016111418002121000_176.1.R39.35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0623"},{"key":"2016111418002121000_176.1.R39.36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/BF03345742","article-title":"High prevalence of simple kidney cysts in patients with primary hyperparathyroidism","volume":"32","author":"Corbetta","year":"2009","journal-title":"Journal of Endocrinological Investigation"},{"key":"2016111418002121000_176.1.R39.37","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/jcb.24832","article-title":"Nuclear translocation of \u03b2-catenin mediates the parathyroid hormone-induced endothelial-to-mesenchymal transition in human renal glomerular endothelial cells","volume":"115","author":"Wu","year":"2014","journal-title":"Journal of Cellular Biochemistry"},{"key":"2016111418002121000_176.1.R39.38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-0035-1549906","article-title":"The effect of parathyroidectomy on insulin sensitivity in patients with primary hyperparathyroidism \u2013 a never ending story?","volume":"123","author":"Cvijovic","year":"2015","journal-title":"Experimental and Clinical Endocrinology and Diabetes"},{"key":"2016111418002121000_176.1.R39.39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0666"},{"key":"2016111418002121000_176.1.R39.40","first-page":"548","article-title":"Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism","volume":"35","author":"Han","year":"2012","journal-title":"Journal of Endocrinological Investigation"},{"key":"2016111418002121000_176.1.R39.41","first-page":"841","article-title":"Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism","volume":"35","author":"Tassone","year":"2012","journal-title":"Journal of Endocrinological Investigation"},{"key":"2016111418002121000_176.1.R39.42","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1210\/jc.2015-2022","article-title":"Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation","volume":"100","author":"Walker","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.43","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0341"},{"key":"2016111418002121000_176.1.R39.44","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e328326f3dd"},{"key":"2016111418002121000_176.1.R39.45","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00241.x"},{"key":"2016111418002121000_176.1.R39.46","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480597"},{"key":"2016111418002121000_176.1.R39.47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1998.00387.x"},{"key":"2016111418002121000_176.1.R39.48","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2001.00926.x"},{"key":"2016111418002121000_176.1.R39.49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2002.00984.x"},{"key":"2016111418002121000_176.1.R39.50","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1210\/jc.2014-1379","article-title":"Renal impairment as a surgical indication in primary hyperparathyroidism: do the data support this recommendation?","volume":"99","author":"Hendrickson","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ckj\/sfu041","article-title":"Metabolic acidosis-induced hypercalcemia in an azotemic patient with primary hyperparathyroidism","volume":"7","author":"Rastegar","year":"2014","journal-title":"Clinical Kidney Journal"},{"key":"2016111418002121000_176.1.R39.52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411701"},{"key":"2016111418002121000_176.1.R39.53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0028"},{"key":"2016111418002121000_176.1.R39.54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1836"},{"key":"2016111418002121000_176.1.R39.55","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2015-2132","article-title":"Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism","volume":"100","author":"Tassone","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.56","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijsu.2016.01.072","article-title":"Does elective parathyroidectomy for primary hyperparathyroidism affect renal function? A prospective study","volume":"27","author":"Egan","year":"2016","journal-title":"International Journal of Surgery"},{"key":"2016111418002121000_176.1.R39.57","doi-asserted-by":"crossref","unstructured":"Viccica G Cetani F Vignali E Miccoli M Marcocci C. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine 2016 Mar [Epub ahead of print]. (doi:10.1007\/s12020-016-0931-8)","DOI":"10.1007\/s12020-016-0931-8"},{"key":"2016111418002121000_176.1.R39.58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030908"},{"key":"2016111418002121000_176.1.R39.59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4158\/EP08178.ORR","article-title":"Alendronate therapy in men with primary hyperparathyroidism","volume":"15","author":"Khan","year":"2009","journal-title":"Endocrine Practice"},{"key":"2016111418002121000_176.1.R39.60","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020890"},{"key":"2016111418002121000_176.1.R39.61","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0166"},{"key":"2016111418002121000_176.1.R39.62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3031"},{"key":"2016111418002121000_176.1.R39.63","doi-asserted-by":"crossref","first-page":"837573","DOI":"10.1155\/2013\/837573","article-title":"Bisphosphonates in CKD patients with low bone mineral density","volume":"2013","author":"Liu","year":"2013","journal-title":"Scientific World Journal"},{"key":"2016111418002121000_176.1.R39.64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6061\/clinics\/2012(Sup01)17","article-title":"Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1","volume":"67","author":"Lourenco","year":"2012","journal-title":"Clinics"},{"key":"2016111418002121000_176.1.R39.65","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090304"},{"key":"2016111418002121000_176.1.R39.66","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.125"},{"key":"2016111418002121000_176.1.R39.67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cen.13055","article-title":"Preoperative diagnosis and prognosis in 40 parathyroid carcinoma patients","volume":"85","author":"Xue","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"2016111418002121000_176.1.R39.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2010.09.025"},{"key":"2016111418002121000_176.1.R39.69","doi-asserted-by":"crossref","unstructured":"Nash E Ranka P Tarigopula G Rashid T. Primary hyperparathyroidism in pregnancy leading to hypercalcemic crisis and uraemic encephalopathy. BMJ Case Report 2015, pii: bcr2014208829. (doi:10.1136\/bcr-2014-208829)","DOI":"10.1136\/bcr-2014-208829"},{"key":"2016111418002121000_176.1.R39.70","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1210\/jc.2015-1110","article-title":"Pregnancy outcomes in women with primary hyperparathyroidism","volume":"100","author":"Hirsch","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.71","doi-asserted-by":"crossref","first-page":"E2794","DOI":"10.1210\/jc.2014-2857","article-title":"Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts","volume":"99","author":"D\u2019Agruma","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00587.x"},{"key":"2016111418002121000_176.1.R39.73","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00038.2006"},{"key":"2016111418002121000_176.1.R39.74","first-page":"375427","article-title":"A single nucleotide polymorphism (rs4236480) in TRPV5 calcium channel gene is associated with stone multiplicity in calcium nephrolithiasis patients","volume":"2015","author":"Khaeel","year":"2015","journal-title":"Mediators of Inflammation"},{"key":"2016111418002121000_176.1.R39.75","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3442"},{"key":"2016111418002121000_176.1.R39.76","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.5.2042"},{"key":"2016111418002121000_176.1.R39.77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1472-6823-14-81","article-title":"A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria","volume":"14","author":"Mastromatteo","year":"2014","journal-title":"BMC Endocrine Disorders"},{"key":"2016111418002121000_176.1.R39.78","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02286"},{"key":"2016111418002121000_176.1.R39.79","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0857"},{"key":"2016111418002121000_176.1.R39.80","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0915"},{"key":"2016111418002121000_176.1.R39.81","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40620-014-0106-8","article-title":"Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene","volume":"28","author":"Vezzoli","year":"2015","journal-title":"Journal of Nephrology"},{"key":"2016111418002121000_176.1.R39.82","doi-asserted-by":"publisher","DOI":"10.1677\/JME-10-0034"},{"key":"2016111418002121000_176.1.R39.83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01213011-200501000-00005","article-title":"Calcium-sensing receptor gene polymorphism Arg990Gly and its possible effect on response to cinacalcet HCl","volume":"15","author":"Rothe","year":"2005","journal-title":"Pharmacogenetic Genomics"},{"key":"2016111418002121000_176.1.R39.84","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0117"},{"key":"2016111418002121000_176.1.R39.85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.semcdb.2015.11.006","article-title":"Calcium-sensing receptor, proinflammatoy cytokines and calcium homeostasis.","volume":"49","author":"Hendy","year":"2016","journal-title":"Seminars in Cell and Developmental Biology"},{"key":"2016111418002121000_176.1.R39.86","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2492"},{"key":"2016111418002121000_176.1.R39.87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300253"},{"key":"2016111418002121000_176.1.R39.88","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1210\/jc.2016-1211","article-title":"Association of mutations in SLC12A1 encoding the NKCC2 cotrasporter with neonatal primary hyperparathyroidism.","volume":"101","author":"Li","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.89","first-page":"1197","article-title":"Rs219780 SNP of claudin 14 gene is not related to clinical expression in primary hyperparathyroidism","volume":"61","author":"Piedra","year":"2015","journal-title":"Clinical Laboratory"},{"key":"2016111418002121000_176.1.R39.90","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00632.2012"},{"key":"2016111418002121000_176.1.R39.91","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000323949","article-title":"Vitamin D receptor genetic polymorphisms and the risk of urolithiasis: a meta-analysis","volume":"86","author":"Lin","year":"2011","journal-title":"Urology International"},{"key":"2016111418002121000_176.1.R39.92","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.5.1690"},{"key":"2016111418002121000_176.1.R39.93","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s002239900685","article-title":"Lack of relationship between BsmI vitamin D receptor polymorphism and primary hyperparathyroidism in a Spanish female population.","volume":"65","author":"Men\u00e0rguez","year":"1999","journal-title":"Calcified Tissue International"},{"key":"2016111418002121000_176.1.R39.94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1365-2796.2000.00593.x","article-title":"The distribution of two different vitamin D receptor polymorphisms\/BsmI and start codon) in primary hyperparathyroidism","volume":"247","author":"Sosa","year":"2000","journal-title":"Journal of International Medicine"},{"key":"2016111418002121000_176.1.R39.95","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1210\/jc.2014-3949","article-title":"Aldosterone, parathyroid hormone, and the use of rennin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis","volume":"100","author":"Brown","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.96","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/HJH.0000000000000927","article-title":"Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial","volume":"34","author":"Tomaschitz","year":"2016","journal-title":"Journal of Hypertension"},{"key":"2016111418002121000_176.1.R39.97","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1450421"},{"key":"2016111418002121000_176.1.R39.98","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/BF03345085","article-title":"Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism","volume":"25","author":"Cetani","year":"2002","journal-title":"Journal of Endocrinological Investigation"},{"key":"2016111418002121000_176.1.R39.99","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0587"},{"key":"2016111418002121000_176.1.R39.100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4158\/EP14537.OR","article-title":"KDIGO categories of glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism","volume":"21","author":"Tassone","year":"2015","journal-title":"Endocrine Practice"},{"key":"2016111418002121000_176.1.R39.101","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1210\/jc.2013-4192","article-title":"Predictors of renal function in primary hyperparathyroidism","volume":"99","author":"Walker","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002121000_176.1.R39.102","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3072"},{"key":"2016111418002121000_176.1.R39.103","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004"},{"key":"2016111418002121000_176.1.R39.104","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-2-200307150-00013"},{"key":"2016111418002121000_176.1.R39.105","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft509"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/176\/1\/R39.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/176\/1\/R39.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:59:38Z","timestamp":1718780378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/176\/1\/R39\/6655052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":105,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/eje-16-0430","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}